Clinical Trials Logo

Clinical Trial Summary

Each year, around 1500 infected Total Hip Arthroplasties (THA) need non-conservative surgery, remaining an issue for patients and healthcare units. The recommended treatment, relying on cohort reviews and international consensus follows a two-stage protocol. This protocol implies a first surgery to remove all infected implants and at least 6 weeks of antibiotic treatment without implant, then usually an antibiotic-free period and only then a second surgery to put back new implants and start the rehabilitation protocol, with usually more than a week of a second hospital stay. Between both surgeries, full-weight bearing is prohibited and joint stiffness and/or pain are rather usual complications. Failure rate is estimated at 10% in this two-stage strategy. The single-stage procedure (i.e. implanting back a new prosthesis during the same surgery after implant removal, synovectomy and lavage) is thought to be less susceptible to late functional complications (i.e. pain, stiffness and muscle deficiency) with a shorter, single hospital stay. Although, with single-stage surgery, infection control could be less efficient because most pathogens produce during the first hours of infection an antibiotic-resistant layer called biofilm, allowing them to colonize and adhere to foreign objects like implants. This single-surgery protocol thus highly relies on antibiotics and has a list of contra-indications (based on experts' consensus): the presence of damaged soft tissues or a sinus tract, unknown pathogens, difficult to treat micro-organisms, severe immunosuppression and for many surgeons, each time a bone graft is necessary. Most of these contra-indications are directly related to the biofilm. As no randomized control trial has ever compared single-stage versus two-stage surgery, the level of evidence for recommending one procedure over the other is low. We conducted a survey that showed that most of the French reference centers have already switched to single stage surgery for single-stage non contra-indicated cases. An antibiotic-loaded hydrogel coating (Defensive Antiadhesive Coating®, Novagenit SRL), has been proven to mechanically prevent the biofilm formation, while allowing a prolonged intraarticular antibiotic release, in a randomized controlled trial in primary prevention of infection in THA. The addition of this biofilm inhibitor to a single-stage surgery might stand as a promising strategy for secondary prevention of peri-prosthetic hip joint infection. Moreover, using this device to prevent biofilm formation could expand one stage surgery to patients that are "normally" contra-indicated to one stage surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04251377
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact Bertrand BOYER, MD
Phone (0)477120820
Email bertrand.boyer@chu-st-etienne.fr
Status Recruiting
Phase N/A
Start date September 30, 2021
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03389646 - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy) Phase 4
Recruiting NCT04119804 - Early Discrimination of Periprosthetic Hip Infections Using Neural Networks (SEPTIC-ANNR)
Terminated NCT05615701 - Image Quality of EOSedge for Radiographic Evaluation of Hip Implant N/A
Completed NCT02660268 - Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections N/A
Recruiting NCT04304885 - Effect of Sonication on Periprosthetic Joint Infection Treatment Strategy.
Recruiting NCT05000723 - Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven
Completed NCT05932823 - Does the Type of Ventilation Affect the Risk for Infections After Hip Replacements?
Completed NCT01963520 - Prosthetic Hip Infections: Prospective Study N/A
Recruiting NCT04488458 - Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections N/A
Completed NCT03161990 - DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?